Oncogene-dependent apoptosis is mediated by caspase-9

AUTOR(ES)

Fearnhead, Howard O.

FONTE

The National Academy of Sciences

RESUMO

Understanding how oncogenic transformation sensitizes cells to apoptosis may provide a strategy to kill tumor cells selectively. We previously developed a cell-free system that recapitulates oncogene dependent apoptosis as reflected by activation of caspases, the core of the apoptotic machinery. Here, we show that this activation requires a previously identified apoptosis-promoting complex consisting of caspase-9, APAF-1, and cytochrome c. As predicted by the in vitro system, preventing caspase-9 activation blocked drug-induced apoptosis in cells sensitized by E1A, an adenoviral oncogene. Oncogenes, such as E1A, appear to facilitate caspase-9 activation by several mechanisms, including the control of cytochrome c release from the mitochondria.

Documentos Relacionados

• α-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis
• Caspase-9 Activation by the Apoptosome Is Not Required for Fas-mediated Apoptosis in Type II Jurkat Cells*
• Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence
• Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia
• Evolutionary conservation of apoptosis mechanisms: Lepidopteran and baculoviral inhibitor of apoptosis proteins are inhibitors of mammalian caspase-9